STOCK TITAN

argenx to Present at the 42nd Annual Cowen Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

February 28, 2022 – argenx (Euronext & Nasdaq: ARGX) announced its participation in the 42nd Annual Cowen Health Care Conference on March 7, 2022, at 2:10 p.m. E.T. Management will engage in a fireside chat during the event. Interested parties can access a live webcast via the Investors section of the argenx website, with a replay available for 90 days after the presentation. argenx specializes in creating innovative therapies for severe autoimmune diseases.

Positive
  • None.
Negative
  • None.


February 28, 2022

Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of management will participate in a fireside chat at the 42nd Annual Cowen Health Care Conference on Monday, March 7, 2022 at 2:10 p.m. E.T.

A live webcast of the presentation may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately 90 days following the presentation.

About argenx

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first-and-only approved neonatal Fc receptor (FcRn) blocker in the U.S. and Japan. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedIn, Twitter, and Instagram.

For further information, please contact:

Media:

Kelsey Kirk
kkirk@argenx.com

Joke Comijn (EU)
jcomijn@argenx.com

Investors:

Beth DelGiacco
bdelgiacco@argenx.com

Michelle Greenblatt
mgreenblatt@argenx.com


FAQ

When is argenx participating in the Cowen Health Care Conference?

argenx will participate in the Cowen Health Care Conference on March 7, 2022, at 2:10 p.m. E.T.

How can I watch the argenx fireside chat?

You can watch the argenx fireside chat via a live webcast on the Investors section of their website.

How long will the replay of the argenx presentation be available?

A replay of the argenx presentation will be available for approximately 90 days after the event.

What is the focus of argenx as a company?

argenx focuses on improving the lives of people suffering from severe autoimmune diseases through innovative antibody-based medicines.

argenx SE American Depositary Shares

NASDAQ:ARGX

ARGX Rankings

ARGX Latest News

ARGX Stock Data

37.04B
59.47M
0%
59.76%
3.47%
Biotechnology
Healthcare
Link
United States of America
Amsterdam